Toxic rise of clozapine plasma concentrations in relation to inflammation (Q44574549)

4 December 2017

Toxic rise of clozapine plasma concentrations in relation to inflammation (English)

1 reference

4 December 2017

0 references

4

1 reference

4 December 2017

6

Philippe A E G Delespaul

1 reference

4 December 2017

Marie Jeanne Haack

1

1 reference

4 December 2017

M L F J Bak

series ordinal

2

1 reference

4 December 2017

Rob Beurskens

series ordinal

3

1 reference

4 December 2017

L M L Stolk

series ordinal

5

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

European Neuropsychopharmacology

4 December 2017

1 reference

4 December 2017

13

1 reference

4 December 2017

5

1 reference

4 December 2017

381-385

1 reference

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Treatment-resistant schizophrenia--the role of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Update on the clinical efficacy and side effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Pharmacokinetics of clozapine and risperidone: a review of recent literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Long-term pharmacokinetics of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Therapeutic drug monitoring of clozapine treatment. Therapeutic threshold value for serum clozapine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Hepatotoxicity of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

EEG alterations in patients treated with clozapine in relation to plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Clozapine plasma level monitoring: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Bacterial pneumonia can increase serum concentration of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Erythromycin-induced clozapine toxic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Seizure following addition of erythromycin to clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Clozapine-induced acute interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Myocarditis and cardiomyopathy associated with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Effects of antipsychotic drugs on cytokine networks

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Modulation of drug metabolism in infectious and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Regulation of cytochromes P450 during inflammation and infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900042-7

7 January 2021

10.1016/S0924-977X(03)00042-7

Identifiers

DOI

1 reference

4 December 2017

1 reference